AVP and preeclampsia: This protective effect may be further mediated by the effect of SSRI exposure on AVP secretion, with more well-controlled depression revealing little amelioration of preeclampsia risk, while more poorly controlled (moderate or severe depression) saw significant benefits of SSRI use on vasopressin release.